Venture In The South

S4:E167 The Weekly Update for Venture and an interview with Saksham Naran, Co-Founder and Vice President of Yuva Biosciences

Venture In The South Season 4 Episode 167

S4:E167 First is The Weekly Update followed by an interview with Saksham Narang, Co-Founder and Vice President of Yuva Biosciences, a longevity startup focused on mitochondrial science to address aging-related conditions. Yuva has developed topical solutions for hair loss, skin wrinkles, and other aging conditions linked to declining mitochondrial function. The company's approach involves identifying molecules that can restore mitochondrial function, as demonstrated by their ingredient Y100. They produce Y100 in-house and then encapsulate it into a silica particle (Zpods) for extended release in the skin. They’ve had strong market adoption of their first OTC product through multiple channel partners and are developing several new products to expand their market penetration to Nutraceuticals for more systemic benefits. Yuva follows a partner licensing model where Yuva provides the encapsulated Y100 in bulk and the partner integrates Y100 into their existing product(s). (interview recorded 4.9.25)

Listen to the All-In Pod Science Corner segment by David Friedberg on therapy for  mitochondrial dysfunction at 1:26:44

Follow David and Paul:

https://x.com/DGRollingSouth

https://x.com/PalmettoAngel

Connect On LinkedIn:

https://www.linkedin.com/in/davidgrisell/

https://www.linkedin.com/in/paulclarkprivateequity/


We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com. Learn more about RollingSouth at rollingsouth.vc or email david@rollingsouth.vc.

People on this episode